Cargando…

WCN23-1139 A Study of Long-Term Outcome of Mycophenolate Dose Modulation in Renal Allograft Recipients With SARS-CoV2 Infection During COVID-19 Pandemic

Detalles Bibliográficos
Autores principales: MEYYAPPAN, J., Bhadauria, D.S., Prasad, N., Veeranki, V., Kaul, A., Patel, M.R., Yachha, M., Behera, M.R., Kushwaha, R.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025619/
http://dx.doi.org/10.1016/j.ekir.2023.02.1037
_version_ 1784909374857150464
author MEYYAPPAN, J.
Bhadauria, D.S.
Prasad, N.
Veeranki, V.
Kaul, A.
Patel, M.R.
Yachha, M.
Behera, M.R.
Kushwaha, R.S.
author_facet MEYYAPPAN, J.
Bhadauria, D.S.
Prasad, N.
Veeranki, V.
Kaul, A.
Patel, M.R.
Yachha, M.
Behera, M.R.
Kushwaha, R.S.
author_sort MEYYAPPAN, J.
collection PubMed
description
format Online
Article
Text
id pubmed-10025619
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-100256192023-03-21 WCN23-1139 A Study of Long-Term Outcome of Mycophenolate Dose Modulation in Renal Allograft Recipients With SARS-CoV2 Infection During COVID-19 Pandemic MEYYAPPAN, J. Bhadauria, D.S. Prasad, N. Veeranki, V. Kaul, A. Patel, M.R. Yachha, M. Behera, M.R. Kushwaha, R.S. Kidney Int Rep Covid-19 and KF (Kidney Failure) Published by Elsevier Inc. 2023-03 2023-03-20 /pmc/articles/PMC10025619/ http://dx.doi.org/10.1016/j.ekir.2023.02.1037 Text en Copyright © 2023 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Covid-19 and KF (Kidney Failure)
MEYYAPPAN, J.
Bhadauria, D.S.
Prasad, N.
Veeranki, V.
Kaul, A.
Patel, M.R.
Yachha, M.
Behera, M.R.
Kushwaha, R.S.
WCN23-1139 A Study of Long-Term Outcome of Mycophenolate Dose Modulation in Renal Allograft Recipients With SARS-CoV2 Infection During COVID-19 Pandemic
title WCN23-1139 A Study of Long-Term Outcome of Mycophenolate Dose Modulation in Renal Allograft Recipients With SARS-CoV2 Infection During COVID-19 Pandemic
title_full WCN23-1139 A Study of Long-Term Outcome of Mycophenolate Dose Modulation in Renal Allograft Recipients With SARS-CoV2 Infection During COVID-19 Pandemic
title_fullStr WCN23-1139 A Study of Long-Term Outcome of Mycophenolate Dose Modulation in Renal Allograft Recipients With SARS-CoV2 Infection During COVID-19 Pandemic
title_full_unstemmed WCN23-1139 A Study of Long-Term Outcome of Mycophenolate Dose Modulation in Renal Allograft Recipients With SARS-CoV2 Infection During COVID-19 Pandemic
title_short WCN23-1139 A Study of Long-Term Outcome of Mycophenolate Dose Modulation in Renal Allograft Recipients With SARS-CoV2 Infection During COVID-19 Pandemic
title_sort wcn23-1139 a study of long-term outcome of mycophenolate dose modulation in renal allograft recipients with sars-cov2 infection during covid-19 pandemic
topic Covid-19 and KF (Kidney Failure)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025619/
http://dx.doi.org/10.1016/j.ekir.2023.02.1037
work_keys_str_mv AT meyyappanj wcn231139astudyoflongtermoutcomeofmycophenolatedosemodulationinrenalallograftrecipientswithsarscov2infectionduringcovid19pandemic
AT bhadauriads wcn231139astudyoflongtermoutcomeofmycophenolatedosemodulationinrenalallograftrecipientswithsarscov2infectionduringcovid19pandemic
AT prasadn wcn231139astudyoflongtermoutcomeofmycophenolatedosemodulationinrenalallograftrecipientswithsarscov2infectionduringcovid19pandemic
AT veerankiv wcn231139astudyoflongtermoutcomeofmycophenolatedosemodulationinrenalallograftrecipientswithsarscov2infectionduringcovid19pandemic
AT kaula wcn231139astudyoflongtermoutcomeofmycophenolatedosemodulationinrenalallograftrecipientswithsarscov2infectionduringcovid19pandemic
AT patelmr wcn231139astudyoflongtermoutcomeofmycophenolatedosemodulationinrenalallograftrecipientswithsarscov2infectionduringcovid19pandemic
AT yachham wcn231139astudyoflongtermoutcomeofmycophenolatedosemodulationinrenalallograftrecipientswithsarscov2infectionduringcovid19pandemic
AT beheramr wcn231139astudyoflongtermoutcomeofmycophenolatedosemodulationinrenalallograftrecipientswithsarscov2infectionduringcovid19pandemic
AT kushwahars wcn231139astudyoflongtermoutcomeofmycophenolatedosemodulationinrenalallograftrecipientswithsarscov2infectionduringcovid19pandemic